Dr David Gene Kastl, MD in Biloxi, MS - Thoracic Surgery (Cardiothoracic Vascular Surgery)

Dr David Gene Kastl, MD is a Thoracic Surgery (cardiothoracic Vascular Surgery) physician based in Biloxi, Mississippi. Dr David Gene Kastl is licensed to practice in South Carolina (license number 29376) and his current practice location is 2001 Claudette Ct, Biloxi, Mississippi. He can be reached at his office (for appointments etc.) via phone at (212) 226-7777.

NPI number for Dr David Gene Kastl is 1679573125 and his current mailing address is 2001 Claudette Ct, Biloxi, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1679573125.

Contact Information

	Dr David Gene Kastl, MD
	2001 Claudette Ct, Biloxi, MS 39531-2420
	(212) 226-7777
	Not Available

Physician's Profile

Full Name	Dr David Gene Kastl
Gender	Male
Speciality	Thoracic Surgery (cardiothoracic Vascular Surgery)
Location	2001 Claudette Ct, Biloxi, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1679573125
Provider Enumeration Date: 07/27/2005
Last Update Date: 01/15/2019

Medical Identifiers

Medical identifiers for Dr David Gene Kastl such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1679573125	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208G00000X	Thoracic Surgery (cardiothoracic Vascular Surgery)	05487R (Louisiana)	Secondary
208G00000X	Thoracic Surgery (cardiothoracic Vascular Surgery)	29376 (South Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David Gene Kastl is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David Gene Kastl, MD 2001 Claudette Ct, Biloxi, MS 39531-2420 Ph: (212) 226-7777	Dr David Gene Kastl, MD 2001 Claudette Ct, Biloxi, MS 39531-2420 Ph: (212) 226-7777

News Archive

BIOTRONIK's Entovis pacemaker system gets FDA approval

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.

Too many kids poisoned with prescription drugs: Study

Figures show that each year half a million kids age 5 and younger get into household medications and are poisoned. Though parents tend to believe that these tragic accidents will never happen to their kids, Dr. Randall Bond, a leading advocate for better prescription drug safety in the home, believes it can happen to anyone.

Research highlights need for expert treatment to manage subarachnoid hemorrhages

Research led by the head of the Barrow Neurological Institute and published in the July 20, 2017 issue of The New England Journal of Medicine reveals that subarachnoid hemorrhages, which are caused by ruptured brain aneurysms, account for 5-10 percent of all strokes and are best managed by experienced and dedicated experts at high-volume centers with neurosurgeons, endovascular surgeons and stroke neurologists.

Global land-use changes increase risk of zoonotic coronavirus transmission from bats

Global land-use changes — including forest fragmentation, agricultural expansion and concentrated livestock production — are creating "hotspots" favorable for bats that carry coronaviruses and where conditions are ripe for the diseases to jump from bats to humans, finds a new analysis by researchers at the Politecnico di Milano, University of California, Berkeley and Massey University.

Scientists identify genetic signature of respiratory syncytial virus

Scientists have identified the genetic signature of respiratory syncytial virus, the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could allow physicians to determine the severity of the infection when symptoms first develop. The study, from a team at The Research Institute at Nationwide Children's Hospital, was published this week in PLOS Medicine.

Dr David Gene Kastl, MD - Thoracic Surgery (Cardiothoracic Vascular Surgery) in Biloxi, MS